SEC Form 4 · accession 0001179110-18-000220
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Villafranca
Director
Period of report
Dec 31, 2017
Accepted (ET)
Jan 3, 2018 · 1:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Share UnitF1,F3,F2 | $0.00 | Dec 31, 2017 | A | 421 | A | Dec 31, 2017 | — | Common Stock | 421 | 90,997 | D |
Explanation of responses
- F1The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis.
- F2The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors.
- F3The deferred share units are fully vested upon issuance.